Upload File

immunological off-target effects of imatinib

prev
next
out of 16
Download Immunological Off-target Effects of Imatinib

Upload: monicadiaz

Post on 06-Jul-2018

221 views

Category:

Documents


0 download

Report

TRANSCRIPT

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    1/16

    http://dx.doi.org/10.1038/nrclinonc.2016.41mailto:[email protected]:[email protected]:[email protected]

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    2/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    3/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    4/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    5/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    6/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    7/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    8/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    9/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    10/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    11/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    12/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    13/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    14/16

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    15/16

    https://clinicaltrials.gov/ct2/show/NCT01738139https://clinicaltrials.gov/ct2/show/NCT01738139https://clinicaltrials.gov/ct2/show/NCT01643278https://clinicaltrials.gov/ct2/show/NCT01643278https://clinicaltrials.gov/ct2/show/NCT02011945https://clinicaltrials.gov/ct2/show/NCT02011945

  • 8/16/2019 Immunological Off-target Effects of Imatinib

    16/16


Report-1 Imatinib and Ginseng

Immunological diagnosis

IMATINIB RESISTANT CML

Immunological Disorders

The DREAM Complex Mediates GIST Cell Quiescence and Is a Novel Therapeutic Target to Enhance Imatinib-Induced Apoptosis Sergei Boichuk, Joshua A. Parry,

Neumonia intersticial inducida por imatinib

AntitumorEffectsofBlockingProteinNeddylation in T315I-BCR ... · tein neddylation, a type of protein turnover mechanism, as a viable therapeutic target against imatinib-resistant

Glivec, INN-imatinib

Immunological Tolerance - judoctor2011.files.wordpress.com · 20.06.2013  · Immunological Tolerance Introduction: Immunological tolerance is the other face of autoimmunity. Autoimmunity

Imatinib mesylate in children and adolescents with cancer · 3 Imatinib mesylate in children and adolescents with cancer Introduction Imatinib mesylate (imatinib, STI 571) is a low

Diagnostic Immunology Topic: Immunological Tolerance Objectives: Define Immunological tolerance Define Immunological tolerance Discuss mechanism of tolerance

Imatinib, c-Abl and cardiotoxicity

Immunological Diseases

A PDE Model for Imatinib-Treated Chronic Myelogenous Leukemiadlevy/papers/cml-pde.pdf · A PDE Model for Imatinib-Treated Chronic Myelogenous Leukemia 1995 drug imatinib has proven

Cholesterol esterification inhibition and imatinib

Immunological Bioinformatics

Immunological testing

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · 1. NAME OF THE MEDICINAL PRODUCT . Imatinib Actavis 50 mg hard capsules . Imatinib Actavis 100 mg hard capsules . ... Imatinib Actavis

Imatinib novartis

Imatinib Therapy for CMLcml-info.com/fileadmin/pictures/Downloads/Imatinib Therapy for CML.pdf · Review properties of imatinib as therapy for CML, ... Schindler T etal. Science 3

Simulation-based systematic review of imatinib …BIB_12575934C0A0...Imatinib PPK & Imatinib PK-PD relationships Simulation-based meta-regression (with-out specific study weighting)

Imatinib Teva, INN-imatinib

Immunological Methods

Immunological Bioinformatics. The Immunological Bioinformatics group Immunological Bioinformatics group, CBS, Technical University of Denmark ()

Neoadjuvant Imatinib, Surgery and then ?

Journal of Immunological Methods - T cell · Journal of Immunological Methods journal homepage: . by the target cell, or from non-target peptides within the chosen HLA allotype

Imatinib Accord, INN- Imatinib

Imatinib cuts mast INSIDE

CML With Imatinib

ORIGINAL ARTICLE Assessment of imatinib as first-line … of imatinib as first... · Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival

Imatinib Accord SPC

Imatinib final,2

Immunological synapse

Haemopoiesis, leukaemia and imatinib : c-fms, a novel target for small molecule inhibitor therapy · Haemopoiesis, Leukaemia & Imatinib: c-fms, a Novel Target for Small Molecule Inhibitor

Imatinib Actavis, INN-imatinib